The BoD is in discussions with the Royal Statistical Society about a possible union.
While the discussions are at an early stage, the BoD believes that a merger could put extra resources behind PSI’s activities leading to greater reach for pharmaceutical statisticians. At this point, the union team would like to share with the membership the pros and cons that have been debated at the BoD and to to solicit feedback on our plans.
No votes or decisions will be taken at this meeting – the objective is to get a feel for the views of the membership to best inform our evaluation of the options in front of PSI.
The BoD is in discussions with the Royal Statistical Society about a possible union.
While the discussions are at an early stage, the BoD believes that a merger could put extra resources behind PSI’s activities leading to greater reach for pharmaceutical statisticians. At this point, the union team would like to share with the membership the pros and cons that have been debated at the BoD and to to solicit feedback on our plans.
No votes or decisions will be taken at this meeting – the objective is to get a feel for the views of the membership to best inform our evaluation of the options in front of PSI.
The BoD is in discussions with the Royal Statistical Society about a possible union.
While the discussions are at an early stage, the BoD believes that a merger could put extra resources behind PSI’s activities leading to greater reach for pharmaceutical statisticians. At this point, the union team would like to share with the membership the pros and cons that have been debated at the BoD and to to solicit feedback on our plans.
No votes or decisions will be taken at this meeting – the objective is to get a feel for the views of the membership to best inform our evaluation of the options in front of PSI.
The BoD is in discussions with the Royal Statistical Society about a possible union.
While the discussions are at an early stage, the BoD believes that a merger could put extra resources behind PSI’s activities leading to greater reach for pharmaceutical statisticians. At this point, the union team would like to share with the membership the pros and cons that have been debated at the BoD and to to solicit feedback on our plans.
No votes or decisions will be taken at this meeting – the objective is to get a feel for the views of the membership to best inform our evaluation of the options in front of PSI.
The BoD is in discussions with the Royal Statistical Society about a possible union.
While the discussions are at an early stage, the BoD believes that a merger could put extra resources behind PSI’s activities leading to greater reach for pharmaceutical statisticians. At this point, the union team would like to share with the membership the pros and cons that have been debated at the BoD and to to solicit feedback on our plans.
No votes or decisions will be taken at this meeting – the objective is to get a feel for the views of the membership to best inform our evaluation of the options in front of PSI.
The BoD is in discussions with the Royal Statistical Society about a possible union.
While the discussions are at an early stage, the BoD believes that a merger could put extra resources behind PSI’s activities leading to greater reach for pharmaceutical statisticians. At this point, the union team would like to share with the membership the pros and cons that have been debated at the BoD and to to solicit feedback on our plans.
No votes or decisions will be taken at this meeting – the objective is to get a feel for the views of the membership to best inform our evaluation of the options in front of PSI.
Date: Ongoing 6 month cycle beginning late April/early May 2024
Are you a member of PSI looking to further your career or help develop others - why not sign up to the PSI Mentoring scheme? You can expand your network, improve your leadership skills and learn from more senior colleagues in the industry.
PSI Training Course: Mixed Models and Repeated Measures
This course is presented through lectures and practical sessions using SAS code. It is suitable for statisticians working on clinical trials, who already have a good understanding of linear and generalised linear models.
Joint PSI/EFSPI Visualisation SIG 'Wonderful Wednesday' Webinars
Our monthly webinar explores examples of innovative data visualisations relevant to our day to day work. Each month a new dataset is provided from a clinical trial or other relevant example, and participants are invited to submit a graphic that communicates interesting and relevant characteristics of the data.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This is an interactive online training workshop providing an in-depth review of the estimand framework as laid out by ICH E9(R1) addendum with inputs from estimand experts, case studies, quizzes and opportunity for discussions. You will develop an estimand in a therapeutic area of interest to your company. In an online break-out room, you will join a series of team discussions to implement the estimand framework in a case study, aligning estimands, design, conduct, analysis, (assumptions + sensitivity analyses) to the clinical objective and therapeutic setting.
Maths Meets Medicine: Exploring Careers in the Pharmaceutical Industry
This session will showcase how careers in pharmaceutical statistics can be both rewarding and impactful, with a focus on how mathematics is integral to the development of medicines. Students will hear from industry experts, explore diverse career paths, and learn why continuing to study math is key to unlocking exciting opportunities in the healthcare sector.
Dissolution Testing: Time for Statistical (r)Evolution
Webinar dedicated to the topic of dissolution of oral solid dosage forms; opportunity to hear from statisticians working in the CMC field, with open question and answers.
In addition, the CMC Statistical Network Europe special interest group will discuss advocacy opportunities, have your say to contribute to the future direction.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.
This networking event is aimed at statisticians that are new to the pharmaceutical industry who wish to meet colleagues from different companies and backgrounds.